[
  {
    "ts": null,
    "headline": "Aetna, a CVS Health company, receives Health Plan of the Year Award from Press Ganey",
    "summary": "Aetna®, a CVS Health® company (NYSE: CVS), today announced that Press Ganey recognized Aetna as its first-ever Health Plan of the Year at their annual Human Experience (HX26) Conference in Orlando, Florida. Press Ganey, the leading provider of experience measurement, data analytics and AI-powered insights to health systems and health plans, presented the award to Steve Nelson, president of Aetna.",
    "url": "https://finnhub.io/api/news?id=2e6cc58c8c6290f4b316ff19873eb5febc1a0560df6e54980a148b270fb20f99",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770325200,
      "headline": "Aetna, a CVS Health company, receives Health Plan of the Year Award from Press Ganey",
      "id": 138368807,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Aetna®, a CVS Health® company (NYSE: CVS), today announced that Press Ganey recognized Aetna as its first-ever Health Plan of the Year at their annual Human Experience (HX26) Conference in Orlando, Florida. Press Ganey, the leading provider of experience measurement, data analytics and AI-powered insights to health systems and health plans, presented the award to Steve Nelson, president of Aetna.",
      "url": "https://finnhub.io/api/news?id=2e6cc58c8c6290f4b316ff19873eb5febc1a0560df6e54980a148b270fb20f99"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right.",
    "summary": "Less than a month after raising its fiscal-year outlook,  Cardinal Health  hiked it again.  The company, which distributes pharmaceuticals and other medical supplies to customers like  CVS Health  said Thursday that it now expects adjusted earnings in the range of $10.15 to $10.35 a share for the current fiscal year.  The new range also is above the $10.02 a share analysts are expecting, according to FactSet.",
    "url": "https://finnhub.io/api/news?id=04ece9ef323b78c73d17f32f976aa7418957e6bdfb7f6cde4a746f071f79ac5e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770313680,
      "headline": "Cardinal Health Stock Jumps After Earnings. Its CEO Explains What Went Right.",
      "id": 138367470,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Less than a month after raising its fiscal-year outlook,  Cardinal Health  hiked it again.  The company, which distributes pharmaceuticals and other medical supplies to customers like  CVS Health  said Thursday that it now expects adjusted earnings in the range of $10.15 to $10.35 a share for the current fiscal year.  The new range also is above the $10.02 a share analysts are expecting, according to FactSet.",
      "url": "https://finnhub.io/api/news?id=04ece9ef323b78c73d17f32f976aa7418957e6bdfb7f6cde4a746f071f79ac5e"
    }
  },
  {
    "ts": null,
    "headline": "Is CVS Health Stock a Bad-News Buy?",
    "summary": "Medicare Advantage rates may not be going up as much as expected in 2027, and that has investors concerned about CVS Health.",
    "url": "https://finnhub.io/api/news?id=a84cb79034c8f67227c191299efda47b0807a36a1d51a962b040e00973d67687",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770309900,
      "headline": "Is CVS Health Stock a Bad-News Buy?",
      "id": 138366237,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Medicare Advantage rates may not be going up as much as expected in 2027, and that has investors concerned about CVS Health.",
      "url": "https://finnhub.io/api/news?id=a84cb79034c8f67227c191299efda47b0807a36a1d51a962b040e00973d67687"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That.",
    "summary": "Less than a month after raising its fiscal-year outlook,  Cardinal Health  hiked it again.  The company, which distributes pharmaceuticals and other medical supplies to customers like  CVS Health  said Thursday that it now expects adjusted earnings in the range of $10.15 to $10.35 a share for the current fiscal year.  The new range also is above the $10.02 a share analysts are expecting, according to FactSet.",
    "url": "https://finnhub.io/api/news?id=d7efb179999113abb06801b37ab322a6d7884f64ab77f6cf8ab5bceda729bbfa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770307980,
      "headline": "Cardinal Health Stock Roars Higher. Another Guidance Boost Can Do That.",
      "id": 138366238,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Less than a month after raising its fiscal-year outlook,  Cardinal Health  hiked it again.  The company, which distributes pharmaceuticals and other medical supplies to customers like  CVS Health  said Thursday that it now expects adjusted earnings in the range of $10.15 to $10.35 a share for the current fiscal year.  The new range also is above the $10.02 a share analysts are expecting, according to FactSet.",
      "url": "https://finnhub.io/api/news?id=d7efb179999113abb06801b37ab322a6d7884f64ab77f6cf8ab5bceda729bbfa"
    }
  },
  {
    "ts": null,
    "headline": "What Analyst Projections for Key Metrics Reveal About CVS Health (CVS) Q4 Earnings",
    "summary": "Besides Wall Street's top-and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.",
    "url": "https://finnhub.io/api/news?id=db2b6f82d06cb676be58ce69980bfa06db8972a3ff15186d4e165596b7d0d71d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770300905,
      "headline": "What Analyst Projections for Key Metrics Reveal About CVS Health (CVS) Q4 Earnings",
      "id": 138364591,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Besides Wall Street's top-and-bottom-line estimates for CVS Health (CVS), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.",
      "url": "https://finnhub.io/api/news?id=db2b6f82d06cb676be58ce69980bfa06db8972a3ff15186d4e165596b7d0d71d"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The Start—PBM 'Spread Pricing' Comes Under Fire",
    "summary": "UnitedHealth Group Inc. (NYSE:UNH), CVS Health Corp. (NYSE:CVS), and Humana Inc. (NYSE:HUM) declined last week, but while investors focused on the Donald Trump administration’s proposed near-zero increase in Medicare Advantage, another major regulatory threat emerged late Thursday that could squeeze the industry’s profits from the other end. Shining A Light On ‘Ghost’ Billions The U.S. Department of Labor (DOL), on Jan. 29, issued a landmark proposed regulation demanding “radical transparency” f",
    "url": "https://finnhub.io/api/news?id=3f4ea303f41fc42bc8c8f7e3e5006c8d467c439f78b50c0b8e582aa8bfdd5104",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770296465,
      "headline": "UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The Start—PBM 'Spread Pricing' Comes Under Fire",
      "id": 138363561,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "UnitedHealth Group Inc. (NYSE:UNH), CVS Health Corp. (NYSE:CVS), and Humana Inc. (NYSE:HUM) declined last week, but while investors focused on the Donald Trump administration’s proposed near-zero increase in Medicare Advantage, another major regulatory threat emerged late Thursday that could squeeze the industry’s profits from the other end. Shining A Light On ‘Ghost’ Billions The U.S. Department of Labor (DOL), on Jan. 29, issued a landmark proposed regulation demanding “radical transparency” f",
      "url": "https://finnhub.io/api/news?id=3f4ea303f41fc42bc8c8f7e3e5006c8d467c439f78b50c0b8e582aa8bfdd5104"
    }
  },
  {
    "ts": null,
    "headline": "CVS Health Helps Customers Accelerate Biosimilar Adoption Through Formulary Changes - Supporting Affordable Options for Osteoporosis Care",
    "summary": "CVS Health® (NYSE: CVS) today announced new steps to further help customers expand adoption of lower-cost biosimilar medications. Effective April 1, 2026, CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity, and Tymlos on major national commercial template formularies. These medications will replace Prolia and Forteo, giving customers and their members more affordable options with strong clinical and supply confidence. This pre",
    "url": "https://finnhub.io/api/news?id=2a726a1b7b586d64968d0ee6eb4100c5f483c469de2fe0e3a586ce272008b16e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770296400,
      "headline": "CVS Health Helps Customers Accelerate Biosimilar Adoption Through Formulary Changes - Supporting Affordable Options for Osteoporosis Care",
      "id": 138363646,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health® (NYSE: CVS) today announced new steps to further help customers expand adoption of lower-cost biosimilar medications. Effective April 1, 2026, CVS Caremark will begin offering osteoporosis biosimilars Ospomyv and Stoboclo, as well as generic teriparatide, Bonsity, and Tymlos on major national commercial template formularies. These medications will replace Prolia and Forteo, giving customers and their members more affordable options with strong clinical and supply confidence. This pre",
      "url": "https://finnhub.io/api/news?id=2a726a1b7b586d64968d0ee6eb4100c5f483c469de2fe0e3a586ce272008b16e"
    }
  },
  {
    "ts": null,
    "headline": "Aetna Launches Simplified, Digital-first, Benefits Onboarding Experience for Members in 2026",
    "summary": "Aetna®, a CVS Health® company (NYSE: CVS) today announces the introduction of an industry leading, fully-digital benefits onboarding experience for four million members during the 2026 welcome season. This technology-enabled offering provides easier navigation and self-service for members by leveraging digital and Rich Communication Services [\"RCS\"] enabled text messaging channels to access the information, resources and support they need at the start of the plan year.",
    "url": "https://finnhub.io/api/news?id=e6d3720502cd75c028207d8b50771e82238acf7132cfcada4603e82988343cbf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770292800,
      "headline": "Aetna Launches Simplified, Digital-first, Benefits Onboarding Experience for Members in 2026",
      "id": 138363647,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Aetna®, a CVS Health® company (NYSE: CVS) today announces the introduction of an industry leading, fully-digital benefits onboarding experience for four million members during the 2026 welcome season. This technology-enabled offering provides easier navigation and self-service for members by leveraging digital and Rich Communication Services [\"RCS\"] enabled text messaging channels to access the information, resources and support they need at the start of the plan year.",
      "url": "https://finnhub.io/api/news?id=e6d3720502cd75c028207d8b50771e82238acf7132cfcada4603e82988343cbf"
    }
  }
]